Cite
MLA Citation
Alana Dikopf et al.. “A safety assessment of crizotinib in the treatment of ALK-positive NSCLC patients.” Expert opinion on drug safety, vol. 14, n.d., pp. 485–493. http://access.bl.uk/ark:/81055/vdc_100025120044.0x00005a
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Alana Dikopf et al.. “A safety assessment of crizotinib in the treatment of ALK-positive NSCLC patients.” Expert opinion on drug safety, vol. 14, n.d., pp. 485–493. http://access.bl.uk/ark:/81055/vdc_100025120044.0x00005a